Department of Urology, Kiziltepe Govermental Hospital, Mardin, Turkey.
Med Hypotheses. 2010 Jan;74(1):83-4. doi: 10.1016/j.mehy.2009.07.038. Epub 2009 Aug 14.
Although premature ejaculation (PE) is a very common male sexual dysfunction there is still no European Medicines Agency (EMEA) or Food and Drug Administration (FDA) approved pharmacological treatment developed for this disease. Ejaculation is a spinal cord reflex where bulbospongiosus and ischiocavernosus muscles play the primary roles. The latest articles provided us that, life-long PE is presumed to have an underlying neurobiological pathophysiology and thus medical therapy would be superior to psychotherapy. Therefore, we hypothesize that the inhibition of the stereotyped rhythmic contractions of these muscles via the injection of botulinum toxin type A, we may have a beneficial effect in treatment of life-long PE.
尽管早泄(PE)是一种非常常见的男性性功能障碍,但目前仍没有获得欧洲药品管理局(EMEA)或美国食品和药物管理局(FDA)批准的用于治疗这种疾病的药物。射精是一种脊髓反射,球海绵体肌和坐骨海绵体肌起着主要作用。最新的研究文章表明,终身性早泄被认为具有潜在的神经生物学病理生理学基础,因此医学治疗将优于心理治疗。因此,我们假设通过注射肉毒毒素 A 来抑制这些肌肉的刻板节律性收缩,可能对治疗终身性早泄有有益的效果。